Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Last Updated: January 27, 2023

Nexgen Pharma Inc Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for NEXGEN PHARMA INC, and what generic and branded alternatives to NEXGEN PHARMA INC drugs are available?

NEXGEN PHARMA INC has thirteen approved drugs.

Summary for Nexgen Pharma Inc

US Patents:	0
Tradenames:	12
Ingredients:	12
NDAs:	13

Drugs and US Patents for Nexgen Pharma Inc

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Nexgen Pharma Inc	PHENDIMETRAZINE TARTRATE	phendimetrazine tartrate	TABLET;ORAL	086020-001	Approved Prior to Jan 1, 1982		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Nexgen Pharma Inc	DIMENHYDRINATE	dimenhydrinate	TABLET;ORAL	085985-001	Approved Prior to Jan 1, 1982		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Nexgen Pharma Inc	PROPOXYPHENE HYDROCHLORIDE	propoxyphene hydrochloride	CAPSULE;ORAL	083185-001	Approved Prior to Jan 1, 1982		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Nexgen Pharma Inc	MECLIZINE HYDROCHLORIDE	meclizine hydrochloride	TABLET, CHEWABLE;ORAL	086392-001	Approved Prior to Jan 1, 1982		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Nexgen Pharma Inc	SODIUM PENTOBARBITAL	pentobarbital sodium	TABLET;ORAL	084238-001	Approved Prior to Jan 1, 1982		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Nexgen Pharma Inc	MEPROBAMATE	meprobamate	TABLET;ORAL	084589-001	Approved Prior to Jan 1, 1982		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Nexgen Pharma Inc

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt

McKinsey

Merck

Medtronic

Moodys

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.